GlassScriptPhysician profile
Marissa Pilitzer
NPI 1376085266
$2,471.69
in general payments reported to CMS, 2019-2025
18 companies · $14.78 in 2025
The $14.78 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $702 · 2022: $530 · 2023: $683 · 2024: $543 · 2025: $14.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $983.89 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $397.04 | 2021-2024 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $200.74 | 2023-2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $197.35 | 2021-2024 | Injectafer |
| Axsome Therapeutics, INC. | $191.45 | 2023-2024 | Sunosi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.29 | 2022-2023 | Trulance, Xifaxan |
| Abbvie INC. | $63.14 | 2023-2024 | |
| Amarin Pharma, INC. | $56.06 | 2021 | |
| Jazz Pharmaceuticals INC. | $52.18 | 2021-2022 | |
| Genentech USA, INC. | $50.93 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.32 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.75 | 2021-2022 | |
| Lilly USA, LLC | $33.93 | 2021-2024 | Zepbound, Mounjaro |
| Pfizer INC. | $31.50 | 2023-2024 | |
| Abbott Laboratories | $23.65 | 2024 | Freestyle Libre 3 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.52 | 2023 | Watchman Flx |
| Bausch Health US, LLC | $13.44 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marissa Pilitzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.